Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Marketing Observational Study of Safety Following Vaccination With Flublok® Compared to Licensed IIV in Adults 18 Years of Age and Older

NCT02600585 is registered in ClinicalTrials.gov with Protein Sciences Corporation as lead sponsor.

NCT NCT02600585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02600585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Marketing Observational Study of Safety Following Vaccination With Flublok® Compared to Licensed IIV in Adults 18 Years of Age and Older
Lead sponsor
Protein Sciences Corporation
Phase
Observational
Overall status
Completed
Start date
November 30, 2015
Completion date
September 30, 2016
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human influenza